Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × LTX-315 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 256 Nivolumab 150 Carboplatin 145 Cyclophosphamide 127 Paclitaxel 120 Cisplatin 117 Dexamethasone 82 Radiotherapy 82 Ipilimumab 75 Magnetic Resonance Spectroscopy 74 Gemcitabine 73 Doxorubicin 69 Rituximab 68 Specimen Handling 66 Etoposide 63 Biopsy 62 Docetaxel 61 Lenalidomide 61 Prednisone 61 Radiation 54 atezolizumab 54 Pemetrexed 50 Bevacizumab 49 Cytarabine 49 Taxes 49 fludarabine 49 Vincristine 48 durvalumab 48 olaparib 45 Fluorouracil 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03725605 2025-12-05

LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)

Lytix Biopharma AS

Phase 2 Completed

6 enrolled 17 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡